87 results
Page 2 of 5
8-K
EX-99.1
75vpp md5yz
9 Nov 23
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2023 Financial Results
4:13pm
8-K
miw66ofsyd41b6eolh5
3 Nov 23
Other Events
4:05pm
8-K
EX-99.1
i3vy0 niw7ysr
3 Nov 23
Other Events
4:05pm
8-K
EX-10.1
4wuczw4bbkkqo pvqn
5 Sep 23
Xilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Scott Coleman, Ph.D., to Chief Development Officer
8:35am
8-K
EX-99.1
lqh5qgulcps 1nhx4vw3
5 Sep 23
Xilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Scott Coleman, Ph.D., to Chief Development Officer
8:35am
8-K
EX-99.2
mqv5frreg1fnd755
14 Aug 23
Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2023 Financial Results
7:40am
8-K
EX-99.1
ar49xjx9nvcn2ta7up
14 Aug 23
Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2023 Financial Results
7:40am
8-K
EX-10.1
8p7fdbik67fghh 47
3 Aug 23
Departure of Directors or Certain Officers
4:15pm
8-K
EX-99.1
jciu 9kchxr33
25 May 23
Regulation FD Disclosure
5:05pm
8-K
EX-99.1
k2c0489
9 May 23
Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2023 Financial Results
7:45am
8-K
EX-10.1
3h5z 69ioak492bd03n
3 Apr 23
Departure of Directors or Certain Officers
4:05pm
S-3
EX-4.4
sy9vv26k6 p2pbyy
9 Nov 22
Shelf registration
4:15pm
S-3
lcad1qpw jmd5shtx0v
9 Nov 22
Shelf registration
4:15pm
S-3
EX-4.5
4eips9s5
9 Nov 22
Shelf registration
4:15pm
S-3
EX-1.2
pj5n04
9 Nov 22
Shelf registration
4:15pm